Sireesh Appajosyula - 13 Nov 2024 Form 4 Insider Report for Tharimmune, Inc. (THAR)

Role
Chief Operating Officer, Director
Signature
/s/ Randy Milby as Attorney-In-Fact for Sireesh Appajosyula
Issuer symbol
THAR
Transactions as of
13 Nov 2024
Net transactions value
+$10,096
Form type
4
Filing time
13 Nov 2024, 17:06:05 UTC
Previous filing
09 Oct 2024
Next filing
14 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction THAR Common Stock Purchase $10,096 +5,000 +87% $2.02 10,758 13 Nov 2024 Direct
holding THAR Common Stock 2,593 13 Nov 2024 See Footnote F1
holding THAR Common Stock 21 13 Nov 2024 See Footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 2,593 shares of common stock are held indirectly by Highpoint Pharmaceuticals, LLC and 21 shares of common stock are held by Channel BioConsulting LLC. The Reporting Person is the managing member of each of Highpoint Pharmaceuticals, LLC and Channel BioConsulting LLC and in such capacity has the right to vote and dispose of the securities held by such entities.